Advanced search×

A chiral ligand-mediated asymmetric addition of a lithium BHA ester enolate to an aldehyde.

Yumiko Y Nomura, Mayu M Iguchi, Hirohisa H Doi, and Kiyoshi K Tomioka

Chem Pharm Bull (Tokyo) 50(8):1131-4 (2002) PMID 12192154

The asymmetric reaction of a lithium enolate generated from a BHA (2, 6-di-tert-buty-4-methoxyphenyl) propanoate was allowed to react with benzaldehyde in the presence of a diether-type chiral ligand affording the corresponding anti-aldol product in a moderate enantioselectivity. A tetradentate ligand induced better enantioselectivity albeit relative loss of anti-selectivity. A variation of lithiating amide agent affected the selectivity, indicating involvement of an amine as a component of the mixed aggregate. Absolute configuration of some of the aldol products was determined by standard transformations.

Version: za2963e q8zaf q8zb9 q8zc9 q8zd0 q8ze1 q8zf1 q8zg1
Buy PDF

Similar articles you may find interesting…

  1. Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity.
    Louise D Archer, Kia J Langford-Smith, and James E Fildes

    J Inherit Metab Dis (2013) PMID 23653226

    I (MPS I), MPS IIIA, MPS IIIB and MPS VII are deficient in the enzymes α-L-Iduronidase, Heparan-N-Sulphatase, N-Acetylglucosaminidase and Beta-Glucuronidase, respectively. Enzyme deficiency leads to the progressive multi-systemic build-up of heparan sulphate (HS) and dermatan sulphate (DS) within c...
    Buy PDF
  2. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?
    Hutan Ashrafian, Leanne Harling, and Thanos Athanasiou

    Metab Brain Dis (2013) PMID 23653255

    We describe the clinical and molecular relationship between obesity and neurodegenerative disease. Secondly we outline the protective role of weight loss, metabolic and caloric modifying interventions in the context of AD and PD. We conclude that the application of caloric restriction through dietar...
    Buy PDF
  3. Quantifying Options for Reducing Coronary Heart Disease Mortality By 2020.
    Mark D Huffman, Donald M Lloyd-Jones, and Simon Capewell

    Circulation (2013) PMID 23661723

    Two contrasting scenarios of change in CVH metrics could prevent 24-30% of the CHD deaths expected in 2020, though with differing impacts by age. Unfavorable continuing trends in obesity and diabetes would have substantial adverse effects. This analysis demonstrates the utility of modelling to infor...
    Buy PDF